Treatment of Acute Respiratory Distress Syndrome (ARDS)
All patients with ARDS must receive lung-protective mechanical ventilation with tidal volumes of 4-8 mL/kg predicted body weight and plateau pressures ≤30 cmH₂O, and patients with severe ARDS (PaO₂/FiO₂ <150 mmHg) must be placed in prone position for at least 12-16 hours daily. 1, 2
Mandatory Ventilation Strategy for All ARDS Patients
Tidal Volume and Pressure Limits
- Set tidal volume at 6 mL/kg predicted body weight (acceptable range 4-8 mL/kg PBW) 1, 2, 3
- Calculate predicted body weight: Males = 50 + 0.91 × [height (cm) - 152.4] kg; Females = 45.5 + 0.91 × [height (cm) - 152.4] kg 2, 4
- Maintain plateau pressure ≤30 cmH₂O as an absolute ceiling 1, 2, 3
- Never exceed 8 mL/kg PBW even if plateau pressures appear acceptable—both parameters must be optimized simultaneously 2, 4
- Target driving pressure (plateau pressure - PEEP) ≤15 cmH₂O, as this predicts mortality better than tidal volume or plateau pressure alone 4, 3
This lung-protective strategy reduces mortality from 39.8% to 31.0% (P=0.007) and increases ventilator-free days compared to traditional higher tidal volumes. 3 The evidence supporting this approach has moderate to high confidence, making it a strong recommendation across all major guidelines. 1
Accept Permissive Hypercapnia
- Allow PaCO₂ to rise and pH to fall to ≥7.20 as a consequence of lung protection 2
- Do not prioritize normocapnia over lung-protective ventilation 2
PEEP Strategy: Titrate Based on ARDS Severity
For Moderate-to-Severe ARDS (PaO₂/FiO₂ <200 mmHg)
- Use higher PEEP (typically >10 cmH₂O) 1, 2, 3
- Higher PEEP reduces mortality in this population (adjusted RR 0.90) 4
- This is a conditional recommendation with moderate confidence 1
For Mild ARDS (PaO₂/FiO₂ 200-300 mmHg)
- Lower PEEP may be appropriate 2
- In patients with cirrhosis or hemodynamic instability, use lower PEEP (<10 cmH₂O) to avoid impairing venous return 2
Monitoring
- Monitor for barotrauma when using PEEP >10 cmH₂O 2
Prone Positioning: Mandatory for Severe ARDS
For severe ARDS with PaO₂/FiO₂ <150 mmHg, implement prone positioning immediately—this is a strong recommendation that reduces mortality (RR 0.74). 1, 2, 4
- Position patient prone for at least 12-16 hours daily 1, 2, 4
- Duration matters: trials with >12 hours/day proning showed mortality benefit, while shorter durations did not 1, 2
- Do not delay prone positioning in severe ARDS—early implementation improves outcomes 2
- Be aware of higher rates of endotracheal tube obstruction (RR 1.76) 1
This intervention has moderate to high confidence in effect estimates and represents one of only two strong recommendations for ARDS treatment. 1
Neuromuscular Blockade: Early Use in Severe ARDS
- For early severe ARDS with PaO₂/FiO₂ <150 mmHg, use neuromuscular blocking agents (cisatracurium) for up to 48 hours 2, 4, 5
- Administer as intermittent boluses rather than continuous infusion when possible 2
- Use continuous infusion only for persistent ventilator dyssynchrony, need for deep sedation, prone positioning, or persistently high plateau pressures 2
Corticosteroids: Recommended for ARDS
Administer systemic corticosteroids to mechanically ventilated patients with ARDS—this represents the most recent high-quality guideline recommendation. 2, 4
- This is a conditional recommendation with moderate certainty of evidence 2
- The American Thoracic Society supports this approach as the most current guidance 2
Fluid Management: Conservative Strategy
- Use a conservative fluid strategy in established ARDS without tissue hypoperfusion 2, 3, 5
- Conservative fluid management improves ventilator-free days without increasing non-pulmonary organ failures 2, 4
Oxygenation Targets
- Target SpO₂ of 88-95% to avoid hyperoxia while maintaining adequate oxygenation 2, 4
- Start supplemental oxygen if SpO₂ <92%, and definitely if <90% 2, 4
- Maintain SpO₂ no higher than 96% in acute hypoxemic respiratory failure 2
Interventions That Are STRONGLY RECOMMENDED AGAINST
High-Frequency Oscillatory Ventilation
- Do not use high-frequency oscillatory ventilation—this is strongly recommended against with high confidence in effect estimates 1, 2, 4, 5
- HFOV may be considered only as rescue therapy in refractory cases, but routine use is harmful 6
Other Interventions to Avoid
- Do not routinely use pulmonary artery catheters for ARDS management 2, 4
- Do not use β-2 agonists for ARDS treatment without bronchospasm 2, 4
- Do not use recruitment maneuvers routinely or for prolonged periods—these are associated with harm 2, 4
Rescue Therapies for Refractory Hypoxemia
VV-ECMO
- For severe refractory ARDS despite optimized ventilation, proning, and rescue therapies, consider VV-ECMO in carefully selected patients at experienced centers 2, 5
- ECMO should only be considered in carefully selected patients due to resource-intensive nature 2
Ventilator Mode Selection
Early Phase of ARDS
- Use volume-controlled ventilation during the early phase because it enables precise monitoring of plateau pressure and driving pressure 3
- There is no mortality or morbidity advantage of pressure-controlled versus volume-controlled ventilation for the same tidal volume 3
Later in Disease Course
- Transition to pressure-controlled ventilation may be appropriate during assisted breathing modes when patient comfort becomes a priority 3
- Critical warning: Pressure-controlled ventilation does not guarantee a fixed tidal volume, which can lead to inadvertent delivery of excessive volumes if lung compliance improves—requires vigilant monitoring of delivered tidal volumes to ensure they remain within 4-8 mL/kg PBW range 3
Sedation and Weaning
- Minimize continuous or intermittent sedation, targeting specific titration endpoints 2, 4
- Use spontaneous breathing trials in patients ready for weaning 2, 4
- Implement a weaning protocol for patients who can tolerate weaning 2, 4
Common Pitfalls to Avoid
- Do not prioritize normocapnia over lung-protective ventilation—accept permissive hypercapnia as necessary 2
- Do not use tidal volumes >8 mL/kg PBW even if plateau pressures are acceptable—both parameters must be optimized 2, 4
- Do not delay prone positioning in severe ARDS—early implementation improves outcomes 2
- Do not apply higher PEEP indiscriminately—tailor to ARDS severity and hemodynamic tolerance 2, 3
- Do not use recruitment maneuvers routinely—conditional recommendation with low confidence, associated with potential harm 1, 2, 4